CLINICAL ROLE -
Alexandra S. Wolff, PharmD, BCOP, discusses use of IDH1 and IDH2 inhibitors in newly diagnosed AML patients and highlights recently released trial data.
Homocysteine Concentration Levels May Predict Risk and Severity of Obstructive Sleep Apnea
Pharmacy Focus Oncology: Advancements in Hematology and Breast Cancer - ASH and SABCS 2023 Recap
The Evolving Treatment Landscape of Multiple Myeloma: GPRC5D-Targeted CAR T-Cell Therapy
Pharmacy Focus: Oncology Edition - Experts See Promising Future for the Treatment of Acute Lymphoblastic Leukemia
Navigating the Rapid Expansion of Cellular Therapies: Challenges and Opportunities for Community and Academic Collaboration
FDA Approves Epcoritamab for Treatment of Relapsed, Refractory Follicular Lymphoma